Vestor Capital LLC decreased its stake in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 99.7% during the first quarter, HoldingsChannel.com reports. The firm owned 687 shares of the financial services provider’s stock after selling 209,355 shares during the period. Vestor Capital LLC’s holdings in Aflac were worth $75,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. Whipplewood Advisors LLC purchased a new position in Aflac during the 1st quarter valued at about $25,000. Groupe la Francaise purchased a new stake in shares of Aflac in the first quarter worth about $25,000. Quarry LP purchased a new stake in shares of Aflac in the fourth quarter worth about $25,000. Nalls Sherbakoff Group LLC bought a new position in shares of Aflac in the fourth quarter valued at approximately $29,000. Finally, Evergreen Advisors LLC bought a new position in shares of Aflac in the first quarter valued at approximately $29,000. Institutional investors own 67.44% of the company’s stock.
Insider Transactions at Aflac
In related news, major shareholder Post Holdings Co. Ltd. Japan sold 63,000 shares of the stock in a transaction on Friday, June 5th. The stock was sold at an average price of $118.12, for a total value of $7,441,560.00. Following the transaction, the insider owned 51,169,435 shares of the company’s stock, valued at $6,044,133,662.20. This represents a 0.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 744,916 shares of company stock valued at $87,118,632 in the last ninety days. 0.80% of the stock is currently owned by insiders.
Aflac Trading Up 0.1%
Aflac (NYSE:AFL – Get Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The financial services provider reported $1.75 EPS for the quarter, missing analysts’ consensus estimates of $1.80 by ($0.05). The company had revenue of $4.24 billion during the quarter, compared to the consensus estimate of $4.20 billion. Aflac had a return on equity of 13.88% and a net margin of 25.60%.Aflac’s quarterly revenue was up 27.9% on a year-over-year basis. During the same period in the previous year, the company earned $1.66 EPS. Analysts expect that Aflac Incorporated will post 7.06 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
AFL has been the topic of a number of analyst reports. Piper Sandler reaffirmed an “overweight” rating and set a $130.00 target price (up from $125.00) on shares of Aflac in a report on Tuesday, May 26th. UBS Group reaffirmed a “neutral” rating and issued a $124.00 price target (up from $114.00) on shares of Aflac in a report on Wednesday, July 8th. Keefe, Bruyette & Woods increased their price objective on Aflac from $115.00 to $120.00 and gave the stock a “market perform” rating in a research report on Monday, July 13th. Morgan Stanley lifted their price objective on Aflac from $120.00 to $125.00 and gave the company an “equal weight” rating in a research note on Thursday, May 21st. Finally, Evercore upgraded Aflac from a “strong sell” rating to a “strong-buy” rating in a research report on Thursday, April 9th. Two equities research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $116.17.
View Our Latest Stock Analysis on Aflac
Aflac Profile
Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.
Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.
See Also
- Five stocks we like better than Aflac
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
